Filtered By:
Drug: Temodar
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 1478 results found since Jan 2013.
Dosimetric Patterns of Failure in the Era of Novel Chemoradiotherapy in Newly-Diagnosed Glioblastoma Patients
CONCLUSION: POF of patients receiving a novel chemotherapy appeared to be influenced by the timepoint of analysis and were increasingly non-central at protocol progression as compared with initial recurrence, suggesting that recurrence originates from the central region. Addition of everolimus and vorinostat appeared to influence POF, despite similar survival outcomes with the temozolomide-only control group. In studies dealing with novel therapeutic agents, robust and properly-timed dosimetric POF analysis may be helpful to evaluate biologic aspects of novel agents.PMID:37385378 | DOI:10.1016/j.radonc.2023.109768
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - June 29, 2023 Category: Radiology Authors: Maasa H Seaberg Tomas Kazda Ryan S Youland Nadia N Laack Deanna H Pafundi S Keith Anderson Jann N Sarkaria Evanthia Galanis Paul D Brown Debra H Brinkmann Source Type: research
Utility of Comprehensive Genomic Profiling for Precise Diagnosis of Pediatric-Type Diffuse High-Grade Glioma
In conclusion, comprehensive genetic and epigenetic analysis should be considered in pediatric brain tumor cases.PMID:37357634 | DOI:10.18926/AMO/65502
Source: Acta Med Okayama - June 26, 2023 Category: Universities & Medical Training Authors: Keigo Makino Yoshihiro Otani Kentaro Fujii Joji Ishida Shuichiro Hirano Yasuki Suruga Kana Washio Kenji Nishida Hiroyuki Yanai Shuta Tomida Daisuke Ennishi Isao Date Source Type: research
